Document Detail


Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
MedLine Citation:
PMID:  16863482     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
STUDY OBJECTIVES: To assess the relative bioavailability of saquinavir after administration with ranitidine alone, ranitidine and food, and food alone; and to investigate the mechanism underlying the effects of pH and food on saquinavir absorption. DESIGN: Single-center, open-label, randomized, three-part crossover, pharmacokinetic pilot study. SETTING: General clinical research center in Scotland. SUBJECTS: Twelve healthy male volunteers. INTERVENTION: Each subject was given a single dose of saquinavir mesylate 600 mg with one of three randomly assigned treatments: ranitidine 150 mg on the evening before and 150 mg on the day of study drug administration, without food (treatment A); ranitidine 150 mg on the evening before and 150 mg on the day of study drug administration, with food (treatment B); and with food alone (treatment C, control). After a 7-day washout period between each of the interventions, subjects received the other two treatments. MEASUREMENTS AND MAIN RESULTS: Blood samples were taken serially for 24 hours after each saquinavir dose, and gastric pH was measured during the 8 hours after dosing. Adverse events were monitored throughout the study. Single doses of saquinavir were well tolerated with or without ranitidine. Of the three treatments, the highest mean maximum plasma concentration (C(max)) and area under the plasma concentration-time curve (AUC) for saquinavir occurred with treatment B; the lowest C(max) and AUC occurred with treatment A. Compared with treatment C (control), saquinavir's bioavailability was 15.9% (90% confidence interval [CI] 10-25%) after treatment A and 167% (90% CI 106-265%) after treatment B. Interindividual variability in both C(max) and AUC was slightly greater after treatments A and B than after treatment C. No correlation was found between pharmacokinetic parameters (C(max) and AUC) and gastric pH parameters, including maximum pH and pH at the time of drug delivery. CONCLUSION: Plasma concentrations of saquinavir were significantly higher when the drug was administered with food and ranitidine than when it was given with food alone. However, these increases were not related to changes in gastric pH caused by ranitidine. It can be postulated that food does not increase the bioavailability of saquinavir through its effect on gastric pH.
Authors:
Thomas N Kakuda; Ronald W Falcon
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pharmacotherapy     Volume:  26     ISSN:  0277-0008     ISO Abbreviation:  Pharmacotherapy     Publication Date:  2006 Aug 
Date Detail:
Created Date:  2006-07-25     Completed Date:  2006-12-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8111305     Medline TA:  Pharmacotherapy     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1060-8     Citation Subset:  IM    
Affiliation:
Hoffman-La Roche Inc., Nutley, New Jersey, USA. TKakuda@tibus.jnj.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Area Under Curve
Biological Availability
Cross-Over Studies
Drug Interactions
Food-Drug Interactions*
Gastric Acid / secretion
Gastric Acidity Determination
Gastric Mucosa / drug effects*,  metabolism
HIV Protease Inhibitors / blood,  pharmacokinetics*
Histamine H2 Antagonists / pharmacology*
Humans
Intestinal Absorption / drug effects
Male
Pilot Projects
Ranitidine / pharmacology*
Reference Values
Saquinavir / blood,  pharmacokinetics*
Scotland
Chemical
Reg. No./Substance:
0/HIV Protease Inhibitors; 0/Histamine H2 Antagonists; 127779-20-8/Saquinavir; 66357-35-5/Ranitidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lack of in vivo correlation between indinavir and saquinavir exposure and cytochrome P450 3A phenoty...
Next Document:  Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients.